Molecule common in some cancers, rheumatoid arthritis leads to potential therapy for both
The study, published in Oncotarget, was led by investigators at Georgetown University Medical Center (GUMC), and included collaborators from Harvard and Columbia Universities, Mayo Clinic and Queen’s University in Belfast, Northern Ireland. "Our findings suggest that cadherin-11 is important for cancer progression as well as rheumatoid arthritis — for reasons we do not fully understand. …